Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Fabino Enterprises's Days Inventory or its related term are showing as below:
BOM:543444'
s Days Inventory Range Over the Past 10 Years
Min: 17 Med: 80.97 Max: 971.76
Current: 17
During the past 8 years, Fabino Enterprises's highest Days Inventory was 971.76. The lowest was 17.00. And the median was 80.97.
BOM:543444's Days Inventory is not ranked
in the Drug Manufacturers industry.
Industry Median: 164.975
vs BOM:543444: 17.00
Fabino Enterprises's Days Inventory
declined
from Mar. 2025 (32.12) to Mar. 2026 (10.56).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Fabino Enterprises's Inventory Turnover for the
six
months ended in Mar. 2026 was 17.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fabino Enterprises's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.06.
Fabino Enterprises (BOM:543444) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Fabino Enterprises's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fabino Enterprises's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Fabino Enterprises Days Inventory Related Terms
Fabino Enterprises Days Inventory Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543444 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's Days Inventory distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a Days Inventory of 10.56 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fabino Enterprises and its competitors. This is 87% below median its historical median of 80.97. Over the past decade, Fabino Enterprises' Days Inventory has ranged from 17.00 to 971.76.
Is Fabino Enterprises' Days Inventory too high?
Fabino Enterprises' current Days Inventory of 10.56 is 87% below median its 10-year median of 80.97. Over the past 10 years, this metric has ranged from a low of 17.00 to a high of 971.76. The Drug Manufacturers industry median Days Inventory is 164.98. Fabino Enterprises' value of 10.56 is 93.6% below this industry median. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' Days Inventory compare to ZTS and UTHR?
Fabino Enterprises' Days Inventory of 10.56 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.98. Fabino Enterprises' value of 10.56 is 93.6% below this benchmark. Historically, Fabino Enterprises' own Days Inventory has ranged from 17.00 to 971.76 over the past decade. While the company's 10-year median is 80.97 vs. the industry median of 164.98, Fabino Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.98, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current Days Inventory of 10.56 is 93.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current Days Inventory is 10.56, which is 87% below median its own 10-year median of 80.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current Days Inventory of 10.56. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current Days Inventory is 10.56, which is 87% below median its 10-year median of 80.97 and 93.6% below the Drug Manufacturers industry median of 164.98. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current Days Inventory is 10.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
Days Inventory: 10.56 (87% below median its 10-year median of 80.97)
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 93.6% below the Drug Manufacturers median
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
